Where patients reveal the biology & QR Genetics discovers solutions. QR Genetics is a computational biology company. We start with real patients, each with a different genetic disease. For every case we resolve the disease mechanism at the protein level, then search the medicines that already exist for one that corrects it. Treating physicians make the clinical decisions, and outcomes are followed over time. Every QR Genetics case creates our proprietary layer of human disease biology: the variant, the mechanism, the drug match and the measured clinical outcome, connected in a knowledge graph that learns from every case. A mechanism resolved in a single patient often drives a much larger disease. That is where our assets come from: programs in cardiovascular, immunology and renal disease, protected by our own patent families, with our lead program heading into clinical validation at Yale. We partner with pharma in two ways: licensing or co-developing our assets, and Disease Biology as a Service (molecule in, indication out; target in, molecule out). qrgenetics.com
| Website | https://qrgenetics.com |
| Employees | 7 (7 on RocketReach) |
| Founded | 2019 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+8 more
(view full list)
|
| Industry | Biotechnology Research, Laboratory Services (Healthcare), Biotechnology |
| Keywords | Drug Discovery, Target Identification, Pharmaceutical Research, Drug Design, New Drug Development, Genetic Research, Pharmaceutical Innovation, Genomics, Innovative Therapeutics, Life Sciences, Therapeutic Development, Drug Repurposing, Biotechnology, Precision Medicine, Molecular Biology, Medicinal Chemistry, Bioinformatics, Clinical Trials |
| Competitors | 23andMe Inc, Ancestry, MyHeritage, Color, Invitae, NeoGenomics Laboratories, Gene by Gene, Fulgent Genetics, GenePlanet, PathAI +33 more (view full list) |
Looking for a particular QRGenetics employee's phone or email?
Moshit Yaffe is the CEO of QRGenetics.
7 people are employed at QRGenetics.